Cargando…
Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome
Barth syndrome (BTHS, OMIM 302060) is a genetic disorder caused by variants of the TAFAZZIN gene (G 4.5, OMIM 300394). This debilitating disorder is characterized by cardio- and skeletal myopathy, exercise intolerance, and neutropenia. TAFAZZIN is a transacylase that catalyzes the second step in the...
Autores principales: | Liang, Zhuqing, Schmidtke, Michael W., Greenberg, Miriam L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184736/ https://www.ncbi.nlm.nih.gov/pubmed/35693555 http://dx.doi.org/10.3389/fmolb.2022.915301 |
Ejemplares similares
-
Barth syndrome: A life-threatening disorder caused by abnormal cardiolipin remodeling
por: Raja, Vaishnavi, et al.
Publicado: (2017) -
Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome
por: Ikon, Nikita, et al.
Publicado: (2018) -
Loss of protein association causes cardiolipin degradation in Barth syndrome
por: Xu, Yang, et al.
Publicado: (2016) -
Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype
por: Bowron, Ann, et al.
Publicado: (2014) -
Blocking phosphatidylglycerol degradation in yeast defective in cardiolipin remodeling results in a new model of the Barth syndrome cellular phenotype
por: Káňovičová, Paulína, et al.
Publicado: (2021)